Cover Image

Efficacy and safety of rituximab in elderly patients with membranous nephropathy

Objectives: Advancing age is a risk factor for treatment-related side effects and mortality in membranous nephropathy (MN) patients treated with traditional immunosuppressive regimens. This study aimed to determine the efficacy and safety of rituximab (RTX) in the treatment of elderly patients with...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yanhong Guo (Author), Huayan Zhao (Author), Mingjing Ren (Author), Yulin Wang (Author), Liuwei Wang (Author), Lin Tang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Rituximab in patients with membranous nephropathy and kidney insufficiency
by: Yanhong Guo, et al.
Published: (2022)

Efficacy and safety of two dose regimens of rituximab for idiopathic membranous nephropathy
by: Zhi-hui Tu, et al.
Published: (2024)

Research advances of factors and mechanisms for therapeutic efficacy of rituximab for primary membranous nephropathy
by: Yu-ting Liu, et al.
Published: (2024)

Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids
by: Xiaofan Hu, et al.
Published: (2024)

Two cases of idiopathic membranous nephropathy treated with rituximab
by: Jae Young Yoon, et al.
Published: (2013)

Dosing optimization of rituximab for primary membranous nephropathy by population pharmacokinetic and pharmacodynamic study
by: Hao Liang, et al.
Published: (2024)

Therapeutic advances of rituximab alone or plus other drugs for membranous nephropathy
by: Chao Zhang, et al.
Published: (2024)

Comparative pharmacoeconomic analysis of rituximab and traditional tacrolimus regimens in membranous nephropathy in China
by: Li Zeng, et al.
Published: (2024)

Evaluating Efficacy and Safety of Tacrolimus Treatment in Membranous Nephropathy: Results of a Retrospective Study of 182 Patients
by: Liang S, et al.
Published: (2023)

Efficacy and safety of cyclosporine A in the treatment of idiopathic membranous nephropathy in an Asian population
by: Lin S, et al.
Published: (2019)

Efficacy and safety of glucocorticoid combined with cyclophosphamide therapy on membranous nephropathy: a systematic review and meta-analysis
by: Chengcheng Feng, et al.
Published: (2024)

Case series of low dose rituximab for membranous nephropathy; a single centre experience
by: Gerry George Mathew, et al.
Published: (2023)

Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis
by: Lin W, et al.
Published: (2019)

Efficacy and Safety of Different Immunosuppressive Therapies in Patients With Membranous Nephropathy and High PLA2R Antibody Titer
by: Le Deng, et al.
Published: (2022)

Effects of CYP3A5 Polymorphisms on Efficacy and Safety of Tacrolimus Therapy in Patients with Idiopathic Membranous Nephropathy
by: Zhang C, et al.
Published: (2020)

Case report: One case of refractory membranous nephropathy with hypokalemia after rituximab infusion was switched to obinutuzumab without recurrence of hypokalemia
by: Yao Zhang, et al.
Published: (2024)

Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?
by: Şafak Mirioğlu, et al.
Published: (2023)

Efficacy and safety of Tripterygium wilfordii multiglucoside for idiopathic membranous nephropathy: a systematic review with bayesian meta-analysis
by: Hongyun Wang, et al.
Published: (2023)

Clinical efficacy and safety of rituximab in lupus nephritis
by: Zhong Z, et al.
Published: (2019)

Efficacy and safety of a modified- 'modified Ponticelli' regimen for treatment of primary membranous nephropathy
by: Indu Ramachandra Rao, et al.
Published: (2019)

Development and External Validation of a Nomogram for Predicting the Effect of RTX on the Treatment of Membranous Nephropathy
by: Guo Y, et al.
Published: (2023)

The efficacy and safety of Sanqi Qushi Granule in patients with idiopathic membranous nephropathy --protocol of a multicenter, randomized control trial (SQ-AUTUMN)
by: Chuang Li, et al.
Published: (2023)

Efficacy and Safety of Prolonged Rituximab Treatment in Patients with Systemic Juvenile Idiopathic Arthritis
by: E. I. Alexeeva, et al.
Published: (2013)

Sexual dimorphic response to rituximab treatment: A longitudinal observational study in a large cohort of patients with primary membranous nephropathy and persistent nephrotic syndrome
by: Annalisa Perna, et al.
Published: (2022)

The efficacy and safety of low-dose rituximab in the treatment of pemphigus vulgaris: a cohort study
by: Xingli Zhou, et al.
Published: (2024)

Efficacy and safety of 12 immunosuppressive agents for idiopathic membranous nephropathy in adults: A pairwise and network meta-analysis
by: Jiarong Liu, et al.
Published: (2022)

Clinical features and short-term outcomes of patients with membranous nephropathy complicated with COVID-19
by: Kai-qi Guo, et al.
Published: (2023)

Overproduction of Mitochondrial Fission Proteins in Membranous Nephropathy in Children
by: Qi-Jiao Wei, et al.
Published: (2018)

Safety of rituximab in rheumatoid arthritis
by: F. Atzeni, et al.
Published: (2011)

Comparison of the efficacy of steroid-free versus classic steroid-containing regimens in primary membranous nephropathy
by: Hui-Lin Xing, et al.
Published: (2024)

Treatment of recalcitrant pemphigoid vegetans in an elderly patient with rituximab
by: Yi-Wei Huang, et al.
Published: (2022)

Efficacy and safety of rituximab dosing for steroid-resistant idiopathic focal segmental glomerulosclerosis: a report of 12 cases
by: Ying-chao Peng, et al.
Published: (2024)

Case Report: Coexistence of Anti-Glomerular Basement Membrane Disease, Membranous Nephropathy, and IgA Nephropathy in a Female PatientWith Preserved Renal Function
by: Wei Qu, et al.
Published: (2022)

Educational Case: Membranous Nephropathy
by: Christina C. Smith MS, et al.
Published: (2018)

Efficacy and Safety of Rituximab in patients with Neuromyelitis Optica Spectrum Disorders: A prospective observation in Iranian Cases.
by: Maral Seyed Ahadi, et al.
Published: (2020)

Research advances of obinutuzumab in the treatment of membranous nephropathy
by: Xiao-jing Lin, et al.
Published: (2024)

Effect of Glomerular Mannose-Binding Lectin Deposition on the Prognosis of Idiopathic Membranous Nephropathy
by: Ying Zhang, et al.
Published: (2020)

Safety and efficacy of rituximab in Malawi: a case for multicentre oncology clinical trials in Africa?
by: Sam M Mbulaiteye
Published: (2021)

Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease
by: Caterina Vacchi, et al.
Published: (2021)

Efficacy and Safety of Rituximab in Children with Refractory Nephrotic Syndrome; A Multicenter Clinical Trial
by: Yo Han Ahn, et al.
Published: (2014)